Skip to main content

This job has expired

You will need to login before you can apply for a job.

2023 Co-op, Technical Development

Employer
Moderna, Inc.
Location
Norwood, MA
Start date
Oct 1, 2022

Job Details

The Role

This is a winter/spring co-op opportunity in Norwood, MA from January June2023. Applicants must be available for the entire duration of the co-op. Start date will be January 9, 2023.

The Technical Development organization at Moderna is looking for top talent in science and engineering to deliver on its mission to design manufacturing processes for mRNA medicines. Co-ops will have an opportunity to be part of high-performing project teams developing new manufacturing platforms to produce mRNA therapeutics and vaccines destined for clinical trials and commercial licensure. You will apply your educational background and learn new technical skills in the synthesis of mRNA, assembly of lipid nanoparticles and formulation of drug products to be administered to patients. You will develop a deep understanding of control strategies to ensure manufacturing processes can consistently deliver mRNA medicines of the highest quality.

Heres What Youll Do:

  • Work with a team of highly skilled experts to come up to speed on technology and techniques.

  • Use laboratory, technical and communication skills to generate experimental results, perform data analysis, and document in formal reports including conclusions and recommended next steps.

  • Perform process scale-up, support technology transfer and provide manufacturing support at internal Moderna, and external contract manufacturing sites.

  • Participate in planning, design, execution, analysis of experiments and formal risk assessments to establish critical process parameters, and overall process control strategies.

  • Optimize the impact of formulation and processing conditions on the stability of mRNA drug products and process intermediates

  • Review and share relevant academic literature and establish new collaborations with internal research and manufacturing groups.

  • Create scaled-down models, and high throughput experimental setups for unit operations

  • Characterize mRNA and lipid nanoparticles through collaboration with the analytical team

  • Prepare technical reports and present finding in cross-functional meetings

  • Additional duties as may be assigned from time to time

Heres What Youll Need (Minimum Qualifications)

  • Current student working towards Bachelors or Masters in Chemical Engineering, Biochemical Engineering, Biomolecular Engineering, Chemistry, Biochemistry/Biophysics, Molecular Biology, Biostatistics, Pharmaceutical Science, Bioengineering or a related field

  • Strong fundamental scientific and engineering skills for the evaluation of experimental data

  • Laboratory skills applicable to bioprocess development and analytical methods

Heres What Youll Bring to the Table (Preferred Qualifications)

  • GPA of 3.5 on a 4 scale or equivalent

  • Demonstrated ability to work both independently as well as the ability to contribute to high performing teams

  • Excellent written and verbal communication skills

  • A desire to make an impact as part of a high-growth, transformational company that is Bold, Relentless, Curious, and Collaborative.

Moderna is pleased to provide you with an innovative suite of benefits, including:

  • Free premium access to meditation and mindfulness classes
  • Free parking or subsidized commuter passes
  • Generous paid time off, including:
    Vacation, sick time and holidays
    Volunteer time to participate within your community
    Discretionary winter shut down
  • Location-specific perks and extras!

Candidates should be aware that Moderna currently maintains a policy requiring all US-based employees to be fully vaccinated against COVID-19 and receive a booster shot once eligible. Newly hired employees must be vaccinated and boosted prior to their employment start date. Moderna is an equal opportunity employer and will provide a reasonable accommodation to those unable to be vaccinated or receive a booster where it is not an undue hardship to the company to do so as provided under federal, state, and local law.

About Moderna

In over 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic.

Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit www.modernatx.com.

Moderna is a smoke-free, alcohol-free and drug-free work environment.

Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a persons race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

-

Company

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.

mRNA is now a turning point in the history of science, medicine, technology, even humankind itself. With this breakthrough discovery, many of the world’s biggest and most challenging medical problems are no longer a question of “how?” but merely a question of “when?”

Come with us as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.

 

Stock Symbol:

MRNA  

Stock Exchange:

USNASDAQ GS

 

Facebook  Instagram  Twitter

 

Company info
Website
Phone
617-714-6500
Location
200 Technology Square
Cambridge, MA
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert